Andrea Tan
Stock Analyst at Goldman Sachs
(1.65)
# 3,417
Out of 5,090 analysts
49
Total ratings
44.74%
Success rate
-5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Neutral | $27 → $48 | $61.44 | -21.88% | 2 | Nov 20, 2025 | |
| INSM Insmed | Maintains: Buy | $196 → $225 | $204.00 | +10.29% | 13 | Oct 31, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.20 | +263.64% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $81.77 | -37.63% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $7.92 | +240.91% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $6.39 | -6.10% | 5 | Jul 1, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $4.24 | -52.83% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $24.34 | -91.78% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $234.13 | -31.66% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.56 | +574.16% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.08 | +270.37% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $577.30 | -35.04% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $8.18 | +878.00% | 2 | May 24, 2022 |
Arrowhead Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $27 → $48
Current: $61.44
Upside: -21.88%
Insmed
Oct 31, 2025
Maintains: Buy
Price Target: $196 → $225
Current: $204.00
Upside: +10.29%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.20
Upside: +263.64%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $81.77
Upside: -37.63%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $7.92
Upside: +240.91%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $6.39
Upside: -6.10%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $4.24
Upside: -52.83%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $24.34
Upside: -91.78%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $234.13
Upside: -31.66%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.56
Upside: +574.16%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.08
Upside: +270.37%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $577.30
Upside: -35.04%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $8.18
Upside: +878.00%